Raffa Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $503K | Buy |
420
+17
| +4% | +$17.4K | 0.06% | 61 |
|
|
2026
Q1 | $370K | Buy |
403
+5
| +1% | +$5.07K | 0.06% | 67 |
|
|
2025
Q4 | $427K | Buy |
398
+8
| +2% | +$7.65K | 0.07% | 65 |
|
|
2025
Q3 | $297K | Sell |
390
-16
| -4% | -$11.9K | 0.05% | 74 |
|
|
2025
Q2 | $316K | Buy |
406
+31
| +8% | +$24.1K | 0.06% | 69 |
|
|
2025
Q1 | $309K | Sell |
375
-7
| -2% | -$5.83K | 0.07% | 64 |
|
|
2024
Q4 | $295K | Sell |
382
-10
| -3% | -$8.28K | 0.07% | 66 |
|
|
2024
Q3 | $347K | Hold |
392
| – | – | 0.08% | 61 |
|
|
2024
Q2 | $354K | Sell |
392
-6
| -2% | -$4.8K | 0.1% | 62 |
|
|
2024
Q1 | $309K | Sell |
398
-7
| -2% | -$4.98K | 0.09% | 67 |
|
|
2023
Q4 | $236K | Buy |
405
+20
| +5% | +$11.7K | 0.07% | 70 |
|
|
2023
Q3 | $207K | Buy |
385
+5
| +1% | +$2.58K | 0.07% | 63 |
|
|
2023
Q2 | $178K | Buy |
380
+2
| +0.5% | +$839 | 0.06% | 68 |
|
|
2023
Q1 | $130K | Buy |
378
+277
| +274% | +$93.4K | 0.05% | 82 |
|
|
2022
Q4 | $37K | Buy |
101
+7
| +7% | +$2.48K | 0.02% | 163 |
|
|
2022
Q3 | $30.4K | Buy |
94
+1
| +1% | +$317 | 0.01% | 170 |
|
|
2022
Q2 | $30.2K | Buy |
93
+6
| +7% | +$1.8K | 0.01% | 173 |
|
|
2022
Q1 | $24.9K | Hold |
87
| – | – | 0.01% | 191 |
|
|
2021
Q4 | $24K | Hold |
87
| – | – | 0.01% | 201 |
|
|
2021
Q3 | $20.1K | Sell |
87
-3
| -3% | -$740 | 0.01% | 192 |
|
|
2021
Q2 | $20.7K | Sell |
90
-2
| -2% | -$402 | 0.01% | 190 |
|
|
2021
Q1 | $17.2K | Buy |
92
+16
| +21% | +$3.13K | 0.01% | 213 |
|
|
2020
Q4 | $12.8K | Hold |
76
| – | – | ﹤0.01% | 226 |
|
|
2020
Q3 | $11.3K | Sell |
76
-1
| -1% | -$155 | ﹤0.01% | 229 |
|
|
2020
Q2 | $12.6K | Buy |
77
+1
| +1% | +$153 | ﹤0.01% | 206 |
|
|
2020
Q1 | $10.5K | Buy |
76
+2
| +3% | +$275 | ﹤0.01% | 204 |
|
|
2019
Q4 | $9.73K | Hold |
74
| – | – | ﹤0.01% | 228 |
|
|
2019
Q3 | $8.28K | Buy |
+74
| New | +$8.24K | ﹤0.01% | 235 |
|
|
2019
Q2 | – | Sell |
-74
| Closed | -$9.6K | – | 1099 |
|
|
2019
Q1 | $9.6K | Hold |
74
| – | – | ﹤0.01% | 194 |
|
|
2018
Q4 | $8.56K | Hold |
74
| – | – | ﹤0.01% | 218 |
|
|
2018
Q3 | $7.94K | Hold |
74
| – | – | ﹤0.01% | 228 |
|
|
2018
Q2 | $6.31K | Hold |
74
| – | – | ﹤0.01% | 231 |
|
|
2018
Q1 | $5.72K | Buy |
+74
| New | +$5.96K | ﹤0.01% | 238 |
|
|
2017
Q4 | – | Sell |
-60
| Closed | -$5.13K | – | 276 |
|
|
2017
Q3 | $5.13K | Hold |
60
| – | – | ﹤0.01% | 234 |
|
|
2017
Q2 | $4.94K | Hold |
60
| – | – | ﹤0.01% | 235 |
|
|
2017
Q1 | $5.05K | Sell |
60
-23
| -28% | -$1.84K | ﹤0.01% | 214 |
|
|
2016
Q4 | $6.11K | Hold |
83
| – | – | ﹤0.01% | 213 |
|
|
2016
Q3 | $6.66K | Hold |
83
| – | – | ﹤0.01% | 203 |
|
|
2016
Q2 | $6.54K | Sell |
83
-550
| -87% | -$41.4K | ﹤0.01% | 197 |
|
|
2016
Q1 | $45.6K | Hold |
633
| – | – | 0.03% | 99 |
|
|
2015
Q4 | $53.3K | Sell |
633
-150
| -19% | -$12.4K | 0.03% | 79 |
|
|
2015
Q3 | $65.5K | Buy |
783
+150
| +24% | +$12.7K | 0.04% | 73 |
|
|
2015
Q2 | $52.8K | Buy |
633
+550
| +663% | +$41.9K | 0.03% | 86 |
|
|
2015
Q1 | $6.03K | Buy |
83
+60
| +261% | +$4.27K | ﹤0.01% | 180 |
|
|
2014
Q4 | $1.59K | Hold |
23
| – | – | ﹤0.01% | 275 |
|
|
2014
Q3 | $1.49K | Buy |
+23
| New | +$1.46K | ﹤0.01% | 279 |
|
|
2014
Q1 | – | Sell |
-23
| Closed | -$1.59K | – | 515 |
|
|
2013
Q4 | $1.59K | Buy |
+23
| New | +$1.15K | ﹤0.01% | 275 |
|
Other funds holding LLY
Raffa Wealth Management's LLY Position: Q2 2026 in Review
Raffa Wealth Management increased its Eli Lilly (LLY) stake by 4.2% in Q2 2026, buying an estimated $17.4K and bringing the position to 420 shares worth $503K. The position accounts for 0.06% of the portfolio, ranked #61.
Raffa Wealth Management first reported a position in LLY in Q4 2013 and has held it in 47 quarters since. 4,431 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Raffa Wealth Management held 420 shares of Eli Lilly worth $503K as of Q2 2026.
- Raffa Wealth Management bought 17 Eli Lilly shares in Q2 2026, an estimated $17.4K.
- Eli Lilly made up 0.06% of Raffa Wealth Management's portfolio in Q2 2026, its #61 holding.
- Raffa Wealth Management first reported a position in Eli Lilly in Q4 2013 and has held it in 47 quarters since.
- 4,431 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.